FFA-Induced Hypertension and Endothelial Dysfunction
NCT00589888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2018-10-16
Summary
The study is a prospective open label study to examine the effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Subjects will receive either 8-hour of intravenous or oral fat loads in either low or high doses or normal saline in random order. Blood samples are drawn and vitals are measured before and after the infusions. Endothelial function and plasma glucose and lipid levels are measured to study the effects.
Conditions
- Endothelial Dysfunction
- Hypertension
Interventions
- DRUG
-
Intralipid 20% @ 20cc/hour
In this arm subjects received Intralipid 20% Intravenous IV continuous infusion at 20cc/hour for 8 hours. The 20% intralipid solution is a long-chain triglyceride emulsion composed of 50% polyunsaturated fatty acids, 26% monounsaturated fatty acids, and 19% saturated fatty acids. During the intralipid infusion studies, subjects remained fasting
- DRUG
-
Intralipid 20%@ 40cc/hour
In this arm subjects received Intralipid 20% IV continuous infusion at 40cc/hour for 8 hours. In this arm subjects will receive Intralipid 20% Intravenous IV continuous infusion at 20cc/hour for 8 hours. The 20% intralipid solution is a long-chain triglyceride emulsion composed of 50% polyunsaturated fatty acids, 26% monounsaturated fatty acids, and 19% saturated fatty acids. During the intralipid infusion studies, subjects remained fasting.
- DRUG
-
Normal Saline
In this arm subjects received 0.9% Normal Saline continuous IV infusion at 40/cc for 8 hours.
- DIETARY_SUPPLEMENT
-
32-gram oral fat load
In this arm subjects received oral liquid fat load prepared by the General Clinical Research Center (GCRC) at baseline and every 2 hours for 6 hours. Participants received fat with Free Fatty Acids (FFA) composed of 33% polyunsaturated fatty acids, 34% monounsaturated fatty acids, and 22% saturated fatty acids. The oral fat load in either low or high dose was given in four equally divided doses at 0, 2, 4, and 6 h.
- DIETARY_SUPPLEMENT
-
64-gram oral fat load
In this arm subjects received 60-gram oral fat load intake at baseline and every 2 hours for 6 hours prepared by the General Clinical Research Center (GCRC). Participants received fat with Free Fatty Acids (FFA) composed of 33% polyunsaturated fatty acids, 34% monounsaturated fatty acids, and 22% saturated fatty acids. The oral fat load in either low or high dose was given in four equally divided doses at 0, 2, 4, and 6 h.
Sponsors & Collaborators
- collaborator OTHER
-
Emory University
lead OTHER
Principal Investigators
-
Guillermo Umpierrez, MD · Emory University SOM/GCRC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2008-04-30
- Completion
- 2008-08-31
Countries
- United States
Study Locations
More Related Trials
-
Metabolic Impact of Fat Digestion
NCT01249378 ·Status: UNKNOWN ·Phase: NA
-
Dietary Fat, Plasma Lipids, and Other CHD Risk Factors
NCT00005532 ·Status: COMPLETED
-
Gut Butyrate and Blood Pressure in African Americans
NCT04415333 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Dietary Fats on Cardiovascular Health and Insulin Sensitivity in Subjects With Abdominal Obesity
NCT01665482 ·Status: COMPLETED ·Phase: NA
-
Effects of Meal Macronutrients on Postprandial Lipids
NCT07313787 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Dietary Intervention and Vascular Function
NCT01478958 ·Status: COMPLETED ·Phase: NA
-
The Role of Dietary Fat on Postprandial Endotoxemia in Healthy Adults
NCT02521779 ·Status: COMPLETED ·Phase: NA
-
Elucidation and Monitoring Postprandial Endothelial Function
NCT00766623 ·Status: COMPLETED ·Phase: NA
-
The Impact of Short-Chain Fatty Acids on Gut Hormone Release After Delivery in the Small and Large Intestine of Healthy Volunteers
NCT06686888 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Short-Chain Fatty Acids in Healthy Individuals
NCT07183488 ·Status: RECRUITING ·Phase: NA
-
Soybean Oil Trial of cArdiovascular Risk
NCT02404207 ·Status: COMPLETED ·Phase: NA
-
Unsaturated Fatty Acids Enriched-diet to Improve Cardiorespiratory Fitness, Metabolic Flexibility and Glucose Tolerance in Obese Patients
NCT03310099 ·Status: COMPLETED ·Phase: NA
-
Trans Fatty Acids and Cardiovascular Risk Factors
NCT00439582 ·Status: COMPLETED ·Phase: NA
-
The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion
NCT01910558 ·Status: WITHDRAWN ·Phase: NA
-
Health Effects of CLA Versus Industrial Trans Fatty Acids
NCT00529828 ·Status: COMPLETED ·Phase: NA
-
Sodium Sensitivity in African Americans
NCT00000536 ·Status: COMPLETED ·Phase: PHASE2
-
Shake It Up: Lipidomics of Lipoproteins and Diet
NCT04120220 ·Status: TERMINATED ·Phase: NA
-
Exploring the Effects of Varying Fat:Carbohydrate Diet Permutations on Gastric Emptying and Metabolic Status Using Human Postprandial Model
NCT05977244 ·Status: UNKNOWN ·Phase: NA
-
Effects of Polyunsaturated Fatty Acids on Intestinal Lipid Metabolism in Insulin-resistant Men
NCT01934543 ·Status: COMPLETED ·Phase: NA
-
Developing Biomarkers of Dietary Intake
NCT01237093 ·Status: COMPLETED ·Phase: PHASE1
-
Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Obesity and HFpEF
NCT03966755 ·Status: COMPLETED ·Phase: NA
-
Impact of Meal Fatty Acids on Postprandial Vascular Reactivity
NCT02144454 ·Status: COMPLETED ·Phase: NA
-
Diets With a Spectrum of Fat Intake for Preventing Obesity: A Randomized Controlled-feeding Trial
NCT02355795 ·Status: COMPLETED ·Phase: NA
-
Postprandial Lipid Metabolism in Patients With Hypertriglyceridemia and Normo-lipidemic Controls: Medium Chain Fatty Acids (MCT) in Comparison to Long-chain, Saturated Fatty Acids (SFA) and Mono-unsaturated Fatty Acids (MUFA)
NCT03846908 ·Status: COMPLETED ·Phase: NA
-
Effects of a High-fat Meal on Exercise-mediated Sympatholysis
NCT06186050 ·Status: COMPLETED ·Phase: NA